Clinical Trial Update: Efficacy and Safety of TD-1473 in Crohn's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update on TD-1473 for Crohn's disease, terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• TD-1473

Snippet

Sponsor: Theravance Biopharma | Conditions: Crohn's Disease | Phase 2 | Status: TERMINATED | Results posted: 2023-03-13